Clinical trial
Afrezza® Dosing Optimization Study
NCT04849845
Study timeline
Study start (actual)2021-04-09Date precision: day
Registry last updated2023-09-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 1unresolved
Diabetes Mellitus, Type 2unresolved
Interventions
Afrezza Dose 1COMBINATION_PRODUCT
Afrezza Dose 2COMBINATION_PRODUCT
Sponsors & collaborators
Mannkind Corporationlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04849845 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.